Gildan and Browning West fight over special shareholder meeting request
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Digital Subscription
One year of digital access for only $205*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*First annual payment billed as $205.00 + GST for one year. This annual subscription will automatically renew at $233.00 + GST every 52 weeks (10% off the regular annual price of $259.35). Offer available to new and qualified returning subscribers only. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Your next Brandon Sun subscription payment will increase by $1.00 and you will be charged $17.95 plus GST for four weeks. After four weeks, your payment will increase to $24.95 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
Hey there, time traveller!
This article was published 22/01/2024 (971 days ago), so information in it may no longer be current.
MONTREAL – Gildan Activewear Inc. has accused a U.S. investment fund of breaking U.S. antitrust rules in increasing its stake in the company and raised concerns about its ability to request a special shareholder meeting to replace of majority of its board.
Browning West is seeking the meeting to replace eight of the company’s 11 board members including chair Donald Berg, and reinstate Gildan co-founder Glenn Chamandy as chief executive.
Gildan alleges the fund did not notify U.S. regulators and comply with a 30-day waiting period before it increased its stake in the company to the point where it could request the shareholder meeting.
Browning West says the company is seeking to invalidate its meeting request based on the false premise that it violated the U.S. Hart-Scott-Rodino Antitrust Improvements Act.
In a letter to shareholders, it said it poses no substantive antitrust concerns to any concerned authority and accused the Gildan board of trying to avoid holding the special meeting.
Gildan has been embroiled in a fight over who should lead the company since it announced late last year that Chamandy would be replaced as chief executive by Vince Tyra. Several Gildan shareholders, including the company’s largest, Jarislowsky Fraser, have sought to have Chamandy reinstated.
This report by The Canadian Press was first published Jan. 22, 2024.
Companies in this story: (TSX:GIL)